Education
About Us
Working with TipRanks
Follow Us
bioMerieux (GB:0RUG)
LSE:0RUG
0RUG Stock Chart & Stats
€95.15
-€0.97(-0.90%)
At close: 4:00 PM EST
€95.15
-€0.97(-0.90%)
Day’s Range― - ―
52-Week Range€90.55 - €128.40
Previous CloseN/A
Volume49.49K
Average Volume (3M)29.23K
Market Cap
€11.22B
Enterprise Value€11.11B
Total Cash (Recent Filing)€569.80M
Total Debt (Recent Filing)€461.40M
Price to Earnings (P/E)32.7
Beta0.83
Next Earnings
Sep 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.00
Shares Outstanding118,361,220
10 Day Avg. Volume61,290
30 Day Avg. Volume29,233
Financial Highlights & Ratios
PEG Ratio-4.00
Price to Book (P/B)3.17
Price to Sales (P/S)3.20
P/FCF Ratio28.72
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€112.40Price Target Upside18.13% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)4.81
Revenue Forecast (FY)€4.26B
Bulls Say, Bears Say
Bulls Say
EarningsOrganic growth for the quarter was 10.3% vs 8.4% for consensus.
Financial GuidanceGuidance was lifted from 6-8% to 8-10% organic sales growth for the full year.
Bears Say
Product PerformanceBIOFIRE installed base growth slowdown may be debated.
bioMerieux News
0RUG FAQ
What was bioMerieux’s price range in the past 12 months?
bioMerieux lowest share price was €90.55 and its highest was €128.40 in the past 12 months.
What is bioMerieux’s market cap?
bioMerieux’s market cap is €11.22B.
When is bioMerieux’s upcoming earnings report date?
bioMerieux’s upcoming earnings report date is Sep 03, 2026 which is in 171 days.
How were bioMerieux’s earnings last quarter?
bioMerieux released its earnings results on Feb 27, 2026. The company reported €2 earnings per share for the quarter, missing the consensus estimate of €2.13 by -€0.13.
Is bioMerieux overvalued?
According to Wall Street analysts bioMerieux’s price is currently Undervalued.
Does bioMerieux pay dividends?
bioMerieux does not currently pay dividends.
What is bioMerieux’s EPS estimate?
bioMerieux’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does bioMerieux have?
bioMerieux has 118,361,220 shares outstanding.
What happened to bioMerieux’s price movement after its last earnings report?
bioMerieux reported an EPS of €2 in its last earnings report, missing expectations of €2.13. Following the earnings report the stock price went up 5.162%.
Which hedge fund is a major shareholder of bioMerieux?
Currently, no hedge funds are holding shares in GB:0RUG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
bioMerieux
bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
0RUG Stock 12 Month Forecast
Average Price Target
€112.40
▲(18.13% Upside)
Technical Analysis
Eurofins Scientific
―
Sartorius Stedim Biotech
―
Sanofi
―
Eurobio-Scientific SA
―
Biosynex SA
―
Options Prices
Currently, No data available
---